Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dalian Qiyunsheng Pharmaceutical is a Chinese pharmaceutical enterprise focused on the development, production, and sale of chemical drugs and Traditional Chinese Medicine (TCM). The company is a prominent manufacturer of glycyrrhizin-based therapies, notably its Compound Glycyrrhizin series used for hepatoprotection and anti-inflammatory purposes in dermatology. Based in Dalian, the company operates GMP-compliant facilities and has established a significant presence in the domestic Chinese market for liver disease and skin condition treatments. Its product line extends to respiratory and cardiovascular health, emphasizing high-quality extraction and formulation technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dalian Qiyunsheng Pharmaceutical.